Literature DB >> 27554032

Materials technology in drug eluting balloons: Current and future perspectives.

Gordon Minru Xiong1, Huiying Ang2, Jinjie Lin2, Yuan Siang Lui1, Jie Liang Phua1, Jing Ni Chan1, Subbu Venkatraman1, Nicolas Foin2, Yingying Huang3.   

Abstract

The coating material technology is important for the delivery of anti-proliferative drugs from the surface of drug-eluting balloons (DEBs), which are emerging as alternatives to drug-eluting stents (DES) in the field of interventional cardiology. Currently, several shortcomings limit their competition with DES, including low drug transfer efficiency to the arterial tissues and undesirable particulate generation from the coating matrix. In this review, we provide a survey of the materials used in existing DEBs, and discussed the mechanisms of actions of both the drugs and coating materials. The type of drug and the influence of the coating material characteristics on the drug uptake, distribution and retention in arterial tissues are described. We also summarize the novel coating excipients under development and provide our perspective on the possible use of nano-scale carriers to address the shortcomings of current coating technology. The scope of this review includes only materials that have been approved for biomedical applications or are generally recognized as safe (GRAS) for drug delivery.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Coating excipient; Drug-eluting balloon; Nanoliposome; Particulate generation; Polymeric nanocarrier

Mesh:

Substances:

Year:  2016        PMID: 27554032     DOI: 10.1016/j.jconrel.2016.08.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

Review 1.  Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview.

Authors:  C D Ramakrishna; Bhargav A Dave; Pankaj S Kothavade; Kajal J Joshi; Ashok S Thakkar
Journal:  J Clin Diagn Res       Date:  2017-06-01

2.  How does the Nature of an Excipient and an Atheroma Influence Drug-Coated Balloon Therapy?

Authors:  Martin Lindsay Buist; Hwa Liang Leo; Karthic Anbalakan; Han Wei Toh; Hui Ying Ang
Journal:  Cardiovasc Eng Technol       Date:  2022-05-23       Impact factor: 2.495

3.  Radiopaque Fully Degradable Nanocomposites for Coronary Stents.

Authors:  Hui Ying Ang; Daniel Toong; Wei Shoon Chow; Welly Seisilya; Wei Wu; Philip Wong; Subbu S Venkatraman; Nicolas Foin; Yingying Huang
Journal:  Sci Rep       Date:  2018-11-27       Impact factor: 4.379

4.  A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease.

Authors:  Hak-Il Lee; Won-Kyu Rhim; Eun-Young Kang; Bogyu Choi; Jun-Hyeok Kim; Dong-Keun Han
Journal:  Pharmaceutics       Date:  2021-04-23       Impact factor: 6.321

5.  Systematic evaluation of particle loss during handling in the percutaneous transluminal angioplasty for eight different drug-coated balloons.

Authors:  Andreas Heinrich; Martin S Engler; Felix V Güttler; Christian Matthäus; Jürgen Popp; Ulf K-M Teichgräber
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.